🇺🇸 FDA
Patent

US 11597727

Inhibitors of integrin alpha 2 beta 1 and methods of use

granted A61PA61P11/06

Quick answer

US patent 11597727 (Inhibitors of integrin alpha 2 beta 1 and methods of use) held by The Regents of the University of California expires Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Mar 07 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
27
CPC classes
A61P, A61P11/06